Share

Artificial hearts will make up for lack of human ones

accreditation
iStock

French biomedical firm Carmat said on Friday it had begun the first human trial of an artificial heart aimed at overcoming shortages of organs available for transplant.

The operation, which took place at the Georges Pompidou Hospital in Paris, "went satisfactorily," it said in a statement.

The patient, whom it did not name, "is conscious and speaking to relatives," Carmat said, adding that it was too early to draw longer-term conclusions about the operation.

Artificial hearts have been in use for many years as a temporary fix for patients awaiting a transplant. But tens of thousands die each year because of a lack of available organs.

The Carmat product aims at providing a longer-term solution to bridge the wait, using biological materials and sensors, rather than a pump, to mimick heart contractions.

The company was authorised in September by French health watchdogs to carry out four trials.

More information

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE